European and U.S. Patent Allowances Strengthen Immunexpress' L...
SEATTLE, Sept. 25, 2018 /PRNewswire-AsiaNet/ -- -- Patent Allowances Relate to SeptiCyte(TM) Technology Using Biomarkers -- These allowances further reinforce the claims of the core family of patents that support the Company's gene expression technology in the detection of host response to ...
Read more https://view-release/?pr-id=75380